COVIDIEN MFG SOLUTIONS S.A. MAHURKAR; CATHETER,INTRAVASCULAR,THERAPEUTIC,SHORT-TERM LESS THAN 30 DAYS
|
Back to Search Results |
|
Model Number 8817143005 |
Device Problem
Break (1069)
|
Patient Problems
Air Embolism (1697); Tachycardia (2095); Radiation Exposure, Unintended (3164)
|
Event Date 10/10/2018 |
Event Type
Injury
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
According to the reporter, quickly after the start of the plasmapheresis session on the patient, a presence of air in the arterial pathway was detected by the machine.They stopped the treatment, clamped the channels and withdrawal of air in the catheter using a syringe was performed.It was stated that the physician decided to have the dressing repaired and change the tip of the arterial pathway due to a suspected crack.At the moment of catheter care, it withdrew alone and the patient rapidly presented respiratory distress and very rapid onset of tachycardia then desaturation.Suspicion of a gas embolism was confirmed by scan.
|
|
Manufacturer Narrative
|
Post market vigilance (pmv) led an evaluation of one device.The visual inspection noted: that the red port ¿ arterial lumen adapter was disengaged from the silicone extension tube and not received.The blue port, clamps, bifurcate and cannula appeared intact.A functional evaluation found that the catheter was submerged into a water bath.The end was clamped, and a syringe was used to inject air to observe leakage.No air bubbles were present.Only the blue port side could be tested.The blue port tested with acceptable results.Records from each manufacturing lot are thoroughly reviewed to ensure that products are released meeting all quality release specifications at the time of manufacture.Replication of the reported condition may occur with improper handling during the clinical application.The root cause of the observed damage was misuse of the product which caused or contributed to the reported condition.No further actions have been deemed necessary at this time.Medtronic, inc.(medtronic) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information in the time allotted and has provided as much information as is available to the company as of the submission date this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic or its employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects" or has "malfunctioned".These words are included in the fda 3500a form and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.Medtronic objects to the use of these words and others like it because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|